A little blue pill is creating a stir in Hollywood—and no, it's not Viagra. It's propranolol, a beta blocker originally designed for heart conditions, that's now making its way into dressing rooms, award ceremonies and ...
Sep 16, 2025
0
0
People with substance use disorder who participate in recovery running programs have shown improved success in maintaining their sobriety and reducing their risk for relapse. These observations led Panayotis Thanos, a University ...
11 hours ago
0
0
A new study illuminates how some areas of the country have been hit much harder than others by the fentanyl epidemic, which took more than 70,800 lives in 2022 alone.
Sep 16, 2025
0
0
As blood cancers are constantly evolving and developing mutations that grow resistance to current treatments, researchers in the University of Cincinnati Cancer Center's Leukemia and Drug Development Lab (LDDL) are constantly ...
Sep 15, 2025
0
0
In pediatric hospitals, emotional comfort is treated as essential to healing. Children are offered music therapy, pet visits, interactive programming, and calming environments—not as extras, but as part of their care. In ...
Sep 15, 2025
0
0
Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice and humans. In mice, a team led by Michael Kaminski was able to ease a key symptom of the difficult-to-treat ...
10 hours ago
0
0
Large pictorial warning labels on smoked tobacco products typically feature confronting images of the harmful health outcomes of smoking. Pictures of diseased lungs, gangrene and mouth decay aim to elicit strong emotional ...
Sep 15, 2025
0
0
University of Massachusetts Amherst researchers and scientists at Embr Labs, a Boston-based start-up, have developed an AI-driven algorithm that can accurately predict nearly 70% of hot flashes before they're perceived. The ...
16 hours ago
0
0
"Liquid biopsy" tests using blood samples to screen for multiple types of cancer are attracting much attention, for their potential to catch unseen tumors.
Sep 16, 2025
0
0
The U.S. Food and Drug Administration released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.
Sep 11, 2025
0
0
